Utilization of Staphylococcal Immune Evasion Protein Sbi as a Novel Vaccine Adjuvant
2019
Co-ligation of the B cell antigen receptor with
complement receptor 2on B-cells via a C3d-opsonised antigen complex significantly lowers the threshold required for B cell activation. Consequently, fusions of antigens with C3d polymers have shown great potential in vaccine design. However, these linear arrays of C3d multimers do not mimic the natural opsonisation of antigens with C3d. Here we investigate the potential of using the unique
complementactivating characteristics of Staphylococcal immune-evasion protein Sbi to develop a pro-vaccine approach that spontaneously coats antigens with C3 degradation products in a natural way. We show that Sbi rapidly triggers the
alternative complement pathwaythrough recruitment of
complementregulators, forming a tripartite complex that acts as a
competitive antagonistof
factor H, resulting in enhanced
complementconsumption. These functional results are corroborated by the structure of this
complementactivating Sbi-III-IV:C3d:FHR-1 complex. Finally, we demonstrate that Sbi, fused with Mycobacterium tuberculosis antigen Ag85b, causes efficient opsonisation with C3 fragments, thereby enhancing the immune response significantly beyond that of Ag85b alone, providing proof of concept for our pro-vaccine approach.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
75
References
27
Citations
NaN
KQI